MicroRNA expression profiles in pediatric dysembryoplastic neuroepithelial tumors

被引:0
作者
M. Braoudaki
G. I. Lambrou
S. A. Papadodima
K. Stefanaki
N. Prodromou
E. Kanavakis
机构
[1] University of Athens,University Research Institute for the Study and Treatment of Childhood Genetic and Malignant Diseases, “Aghia Sophia” Children’s Hospital
[2] University of Athens Medical School,First Department of Pediatrics, Hematology and Oncology Unit, Choremeio Research Laboratory, “Aghia Sophia” Children’s Hospital
[3] University of Athens,Department of Forensic Medicine and Toxicology, School of Medicine
[4] Children’s Hospital “Aghia Sophia”,Department of Pathology
[5] Children’s Hospital “Aghia Sophia”,Department of Neurosurgery
来源
Medical Oncology | 2016年 / 33卷
关键词
Pediatric; Brain tumors; MicroRNA microarrays; qRT-PCR; Biomarkers; ROC curves;
D O I
暂无
中图分类号
学科分类号
摘要
Among noncoding RNAs, microRNAs (miRNAs) have been most extensively studied, and their biology has repeatedly been proven critical for central nervous system pathological conditions. The diagnostic value of several miRNAs was appraised in pediatric dysembryoplastic neuroepithelial tumors (DNETs) using miRNA microarrays and receiving operating characteristic curves analyses. Overall, five pediatric DNETs were studied. As controls, 17 samples were used: the FirstChoice Human Brain Reference RNA and 16 samples from deceased children who underwent autopsy and were not present with any brain malignancy. The miRNA extraction was carried out using the mirVANA miRNA Isolation Kit, while the experimental approach included miRNA microarrays covering 1211 miRNAs. Quantitative real-time polymerase chain reaction was performed to validate the expression profiles of miR-1909* and miR-3138 in all samples initially screened with miRNA microarrays. Our findings indicated that miR-3138 might act as a tumor suppressor gene when down-regulated and miR-1909* as a putative oncogenic molecule when up-regulated in pediatric DNETs compared to the control cohort. Subsequently, both miRNA signatures might serve as putative diagnostic biomarkers for pediatric DNETs.
引用
收藏
相关论文
共 171 条
[1]  
Chassoux F(2013)Dysembryoplastic neuroepithelial tumors: where are we now? Epilepsia 54 129-134
[2]  
Daumas-Duport C(2015)Seizures in children with dysembryoplastic neuroepithelial tumors of the brain–A review of surgical outcomes across several studies Childs Nerv Syst 31 847-855
[3]  
Ranger A(2010)Dysembryoplastic neuroepithelial tumors: a prospective clinicopathologic and outcome study of 13 children Pediatr Neurol 43 395-402
[4]  
Diosy D(2010)Dysembryoplastic neuroepithelial tumors and gangliogliomas: clinical results of 52 patients Acta Neurochir (Wien) 152 1661-1671
[5]  
Spalice A(2011)One hundred and one dysembryoplastic neuroepithelial tumors: an adult epilepsy series with immunohistochemical, molecular genetic, and clinical correlations and a review of the literature J Neuropathol Exp Neurol 70 859-878
[6]  
Ruggieri M(2010)Dysembryoplastic neuroepithelial tumors and cognitive outcome: cure at a price? Cancer 116 5461-5469
[7]  
Grosso S(2014)Weight of epilepsy in brain tumor patients J Neurooncol 118 385-393
[8]  
Verrotti A(2013)Suicide ideation in pediatric and adult survivors of childhood brain tumors J Neurooncol 113 425-432
[9]  
Polizzi A(2015)Therapeutic use of MicroRNAs in cancer Anti-Cancer Agents Med Chem 16 7-19
[10]  
Magro G(2015)MicroRNAs in pediatric central nervous system embryonal neoplasms: the known unknown J Hematol Oncol 8 6-2627